Cancerbackup: Graft versus host disease

Skip the page content navigation if you do not require links to content sections within this page.

Page Content Navigation

Skip the main banner if you do not want to read it as the next section.


Page Banner

Want to speak to a specialist cancer nurse? Call free on 0808 800 1234



The best cancer information for everyone.
Cancerbackup has merged with Macmillan. Together we can provide a wealth of high quality information about cancer.


Skip the main content if you do not want to read it as the next section.


Graft-versus-host disease


If you have had stem cells from a donor, even a brother or sister, there is a possibility that the new cells (the graft) will react against your tissues (the host). This reaction is called graft versus host disease (GvHD). This happens when the donor’s immune system attacks the patient’s body. You will be prescribed medicines to prevent GvHD happening, so it is usually mild. However, in some people it can become very severe and even life-threatening. It mainly affects the skin, the gut (stomach and bowel) and the liver. The reaction can occur up to six months after your transplant.

Occasionally the donor’s bone marrow may be treated (purged) with antibodies to remove a type of white blood cell (T-lymphocyte) which is thought to cause the GvHD. Removing the T-lymphocytes is most often done if a severe graft versus host reaction is possible – for example, if bone marrow from an unrelated donor is used.

If GvHD occurs, it does not mean that the transplant has failed. It may even be helpful, as some of the cells involved in the reaction may also attack any cancer cells in the body that have survived the high-dose treatment.




Content last reviewed: 01 June 2006
Page last modified: 14 January 2009

Get support

Look for other people in the same situation on our What Now? community - read their blogs or talk to them in our chat rooms.

Find out about other ways to get support on the main Macmillan website.